Bank of Montreal
AGN

Bank of Montreal’s Allergan plc AGN Stock Holding History

Bank of Montreal’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,400
Closed -$1.23M – 5188
2019
Q1 		$1.23M Buy
8,400
+1,200
+17% +$174K ﹤0.01% 1937
2018
Q4 		$962K Buy
+7,200
New +$1.18M ﹤0.01% 1912

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bank of Montreal's AGN Position: Q2 2020 in Review

Bank of Montreal sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 529,681 shares — an estimated $94M sold.

Bank of Montreal first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $267M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bank of Montreal reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bank of Montreal sold 529,681 Allergan plc shares in Q2 2020, an estimated $94M.
  • Bank of Montreal first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Bank of Montreal's Allergan plc position peaked at $267M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.